<DOC>
	<DOC>NCT00572091</DOC>
	<brief_summary>Improvement in heart failure with moderate to severe mitral regurgitation using a percutaneously delivered implanted device</brief_summary>
	<brief_title>Aachen Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>Symptomatic heart failure functional MR 2+ 4+ LVEF 20% 50% MR of organic origins significant comorbidities</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Mitral Regurgitation</keyword>
</DOC>